Article
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Clinical chemistry - 1 Mar 2021
Giménez-Capitán Ana, Bracht Jillian, García Juan José, Jordana-Ariza Núria, García Beatriz, Garzón Mónica, Mayo-de-Las-Casas Clara, Viteri-Ramirez Santiago, Martinez-Bueno Alejandro, Aguilar Andrés, Sullivan Ivana-Gabriela, Johnson Eric, Huang Chung-Ying, Gerlach Jay L, Warren Sarah, Beechem Joseph M, Teixidó Cristina, Rosell Rafael, Reguart Noemí, Molina-Vila Miguel A
Abstract excerpt
BACKGROUND: With the advent of precision oncology, liquid biopsies are quickly gaining acceptance in the clinical setting. However, in some cases, the amount of DNA isolated is insufficient for Next-Generation Sequencing (NGS) analysis. The nCounter platform could be an alternative, but it has never been explored for detection of clinically relevant alterations in fluids. METHODS: Circulating-free DNA (cfDNA) was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
